Amgen, Inc. (AMGN)
331.17
+0.76
(+0.23%)
USD |
NASDAQ |
Jan 20, 16:00
332.61
+1.44
(+0.43%)
After-Hours: 20:00
Amgen Market Cap: 178.33B for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 154.23B |
| Johnson & Johnson | 525.64B |
| Eli Lilly & Co. | 932.04B |
| Merck & Co., Inc. | 271.78B |
| Regeneron Pharmaceuticals, Inc. | 77.11B |
Market Cap Related Metrics
| PE Ratio | 25.60 |
| PS Ratio | 4.997 |
| PEG Ratio | 0.3901 |
| Price to Book Value | 18.54 |
| Price to Free Cash Flow | 15.54 |
| Price | 331.17 |
| Earnings Yield | 3.91% |
| PEGY Ratio | 0.3738 |
| Operating PE Ratio | 17.49 |
| Normalized PE Ratio | 22.07 |